The prognostic value of the controlling nutritional status score in patients with multiple myeloma.


Journal

Leukemia & lymphoma
ISSN: 1029-2403
Titre abrégé: Leuk Lymphoma
Pays: United States
ID NLM: 9007422

Informations de publication

Date de publication:
08 2020
Historique:
pubmed: 21 4 2020
medline: 28 4 2021
entrez: 21 4 2020
Statut: ppublish

Résumé

The Controlling Nutritional Status (CONUT) score predicts the prognosis in several tumors. However, its prognostic significance in multiple myeloma (MM) remains unclear. The present study investigated the correlation between the CONUT score and the survival outcomes of MM patients. A total of 178 patients newly diagnosed with MM were retrospectively enrolled. Patients with a high CONUT score (≥5) had a significantly shorter median overall survival (OS) than those with a low CONUT score (≤4) (33 vs. 57 months,

Identifiants

pubmed: 32306801
doi: 10.1080/10428194.2020.1749608
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1894-1900

Auteurs

Takahiro Kamiya (T)

Department of Hematology, Yokohama Municipal Citizen's Hospital, Yokohama, Japan.
Division of Hematology, Keio University School of Medicine, Tokyo, Japan.

Chisako Ito (C)

Department of Hematology, Yokohama Municipal Citizen's Hospital, Yokohama, Japan.

Yuriko Fujita (Y)

Department of Hematology, Yokohama Municipal Citizen's Hospital, Yokohama, Japan.

Shinji Ogura (S)

Department of Hematology, Yokohama Municipal Citizen's Hospital, Yokohama, Japan.

Kota Mizuno (K)

Department of Hematology, Yokohama Municipal Citizen's Hospital, Yokohama, Japan.
Division of Hematology, Keio University School of Medicine, Tokyo, Japan.

Aki Sakurai (A)

Department of Hematology, Yokohama Municipal Citizen's Hospital, Yokohama, Japan.

Yoshinobu Aisa (Y)

Department of Hematology, Yokohama Municipal Citizen's Hospital, Yokohama, Japan.

Tomonori Nakazato (T)

Department of Hematology, Yokohama Municipal Citizen's Hospital, Yokohama, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH